Applied Therapeutics shares are trading higher after the FDA communicated that an advisory committee meeting would no longer be required.
Portfolio Pulse from Benzinga Newsdesk
Applied Therapeutics shares rose after the FDA announced that an advisory committee meeting is no longer required for the company.
September 18, 2024 | 11:42 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Applied Therapeutics shares increased following the FDA's decision to forego an advisory committee meeting, which is a positive regulatory development for the company.
The FDA's decision to not require an advisory committee meeting is typically seen as a positive sign, suggesting confidence in the company's application. This news likely led to the increase in APLT's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100